Unbatched lot — LP3-R 30mg — third-party test record
This page is the permanent record for one lot of material: what was tested, by which laboratory, under which method, and what the report says. The report images below are the source documents.
Test summary
| Test | Compound | Presentation | Lot | Date | Laboratory | Method | Standard | Result | Criterion |
|---|---|---|---|---|---|---|---|---|---|
| Purity | LP3-R | 30mg | not stated on report | 10/8/2025 | Vanguard Laboratory, A2LA cert 6377.01.01 | HPLC-UV/VIS | — | >99.80% | — |
| Purity | LP3-R | 30mg | not stated on report | 09 OCT 2025 | Janoshik | HPLC | — | 99.664% | — |
The reports
What these tests measure
Purity
A purity assay separates the sample on a reversed-phase HPLC column and reports the target peak as a percentage of total peak area.
It answers one analytical question only: how much of the material in the vial is the identified compound, and what else is present.
Further reading: our testing methodology.
Other records
- Purity test records (HPLC)
- Bacterial endotoxin records (LAL, USP <85>)
- Residual-solvent records (GC)
- Heavy-metal records (ICP-MS)
Cite this record
Licensed Peptides, Lot not stated on report test record (LP3-R 30mg), retrieved 5 November 2026, https://licensedpeptides.com/lab-reports/unbatched-lp3-r-30mg/.
Data on this page is published under CC BY 4.0. Reuse it, with attribution. Machine-readable copies: data.csv · data.json.
For laboratory research use only. Not for human or veterinary use.